G W thoe Schwartzenberg1, Y M Buys. Show Affiliations » 1. Department of Ophthalmology, University of Toronto, Ont.
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, TopicalAdultAnti-Inflammatory Agents/adverse effectsAnti-Inflammatory Agents/therapeutic useBetamethasone Valerate/adverse effectsBetamethasone Valerate/therapeutic useDermatitis/drug therapyDiflucortolone/adverse effectsDiflucortolone/analogs & derivativesDiflucortolone/therapeutic useEczema/drug therapyEyelid Diseases/drug therapyFemaleGlaucoma/chemically inducedGlaucoma/drug therapyGlucocorticoidsHumansIntraocular PressureMaleOintmentsScotoma/chemically inducedVisual Fields
Substances: See more » Anti-Inflammatory AgentsGlucocorticoidsOintmentsdiflucortolone valerateBetamethasone ValerateDiflucortolone
Year: 1999 PMID: 10396659
Source DB: PubMed Journal: Can J Ophthalmol ISSN: 0008-4182 Impact factor: 1.882